tiprankstipranks
Advertisement
Advertisement

iRadimed sees Q2 EPS 44c-48c, consensus 47c

Sees Q2 revenue $20M-$21M, consensus $21.13M. “Looking ahead, for the second quarter of 2026 financial guidance, we expect revenue of $20.0 million to $21.0 million, GAAP diluted earnings per share of $0.40 to $0.44, and non-GAAP diluted earnings per share of $0.44 to $0.48.”

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1